DYAI
NASDAQ
$1.47
Dyadic International Inc DE (DYAI)
Dyadic International, Inc., a biotechnology platform company, develops, produces and sells enzymes and other proteins in the United States. The company is headquartered in Jupiter, Florida.
Sector:
Healthcare
Industry:
Biotechnology
Target: $6 (+308.16%)
Market Cap
$44M
Free Cash Flow Yield
-12.86%
Beta (5Y)
0.48
Price Chart
Valuation
Market Cap$44M
Forward P/E15.82
P/S11.58
P/B21.01
Profitability
Total Revenue (TTM)$3.81M
Gross Profit (TTM)$994K
EBITDA-$7.29M
Profit Margin-191.5%
Operating Margin-172.1%
EPS-$0.21
Financial Health
Free Cash Flow Yield-12.86%
Growth & Risk
EPS 5Y CAGR-7.16%
Revenue 5Y CAGR+19.03%
FCF 5Y CAGR-3.54%
Beta (5Y)0.48
Sharpe Ratio0.86